Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by MMABStraderon Apr 10, 2022 3:41pm
137 Views
Post# 34592108

RE:RE:RE:RE:RE:This line says it all...

RE:RE:RE:RE:RE:This line says it all...
Accountprince...  Your head and my head are in two different places.  I think the glass is half full and you think it's half empty.  I think your response to my post was a bunch of jibberish.

Yes, I have been disappointed by the delays in the PMX and the DIMI trials. But I think the end game will be rewarding for all Spectral shareholders.

Yes, it's disappointing that U.S. shareprice reached 60 cents a share in Feb 2021, but I sold 25% of my position around 55 cents a share at that time and bought those shares back in Nov 2021 around 20 cents a share. Plus, I was  buying additional shares into the first week of 2022.

If you want to be a successful investor (I have bought stocks for the last 50 years), have a well thought out plan.  Stick to the plan and don't overthink it.
<< Previous
Bullboard Posts
Next >>